UL To Expand Services at New Mounds View, Minnesota, Location
08/07/2013
UL said it is relocating from its current location southeast of Mounds View, in Vadnais Heights, to expand on its existing high-tech and medical safety engineering and testing services to now offer local Human Factors Engineering services, Home Healthcare as well as access to comprehensive services to support medical and IVD manufacturers with regulatory submissions in global markets.
"Minnesota has one of the most active and innovative medical device clusters in the nation and we are pleased to be able to place some of our top talent to support this area locally," said Joe Madden, Global Sales Director for UL's Health Sciences Division. "Now manufacturers have local access to the full product lifecycle services UL provides to support challenges that manufacturers face when trying to get their approvals."
In 2012, UL acquired Wiklund R&D located in Concord, MA, bringing years of knowledge in Human Factors Engineering for medical and other devices. The new office in Mounds View Minnesota will be the first major expansion of that service within North America.
Project Announcements
Wyandot Snacks Expands Marion, Ohio, Production Operations
08/29/2025
Trane Technologies Expands Fort Smith, Arkansas, Operations
08/29/2025
BioMADE Plans Boone, Iowa, Bioindustrial Manufacturing Operations
08/29/2025
Choice Fabricators Expands Rainbow City, Alabama, Production Operations
08/29/2025
Ranovus Expands Ottawa, Ontario, Semiconductor Operations
08/29/2025
Belgium-Based Stow Group Plans Gordon County, Georgia, Manufacturing Operations
08/28/2025
Most Read
-
Tariffs, Talent, and U.S. Expansion
Q3 2025
-
What We’re Getting Wrong About Gen Z’s Future in the Skilled Trades
Q3 2025
-
Data Center Demand Stabilizes Amid Changing Market Forces
Q3 2025
-
A New Course for U.S. Shipbuilding
Q3 2025
-
Optimizing Your Rail-Served Transportation Network: Strategy Before Steel
Q2 2025
-
In Focus: AI Is Changing Incentives Math
Q2 2025
-
Rewriting the Rules of Warehouse ROI
Q3 2025